Mounjaro vs Compounded Tirzepatide
Both deliver tirzepatide — the dual GIP/GLP-1 receptor agonist — but via different regulatory pathways. Mounjaro is the ARTG-registered Eli Lilly product; compounded tirzepatide is dispensed under TGA SAS-B by a licensed Australian compounding pharmacy.
Mounjaro vs Compounded tirzepatide — head to head
| Attribute | Mounjaro | Compounded tirzepatide |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| Regulatory pathway | ARTG-registered, standard private script | TGA SAS-B / Authorised Prescriber |
| Where dispensed | Any Australian pharmacy | TGA-licensed compounding pharmacy |
| Delivery format | Single-use pre-filled pen | Multi-dose vial + syringes |
| AUD cost / month | ~$400–$650 private | Per-case; often $300–$550 depending on dose |
| Dose flexibility | Fixed pen strengths | Prescriber-set, vial concentration variable |
Verdict
Mounjaro is the default when supply allows — standardised dose, ARTG-registered, dispensed at any Australian pharmacy. Compounded tirzepatide is a per-case clinical decision when there is documented clinical need or supply constraint.
Frequently asked questions
- Is compounded tirzepatide legal in Australia?
- Yes — when prescribed by an AHPRA-registered Australian doctor under TGA SAS-B and dispensed by a TGA-licensed Australian compounding pharmacy. It is not legal to import yourself or buy from offshore vendors.
- Can I switch from compounded tirzepatide to Mounjaro?
- Yes, with your prescriber's review — dose-match against your current titration and confirm pen strength availability. Most Australian prescribers will use Mounjaro as the default when supply is available.
Read the full profiles
GLP-1 / GIP weight management
Tirzepatide
Dual GIP/GLP-1 receptor agonist for clinically supervised weight management — accessed in Australia via ARTG product or SAS-B compounded preparations.
GLP-1 / GIP weight management
Mounjaro (Tirzepatide)
Mounjaro (tirzepatide) is ARTG-registered in Australia — here's how access, cost, and prescribing work in 2026.
Other comparisons
Be assessed by an Australian doctor
Take the free 5-minute intake. An AHPRA-registered Australian doctor will review your case and discuss the right molecule and pathway for you.
Start free assessment All peptides